{"title":"NTP monograph on health effects of low-level lead.","authors":"","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Although reductions in lead (Pb) exposure for the U.S. population have resulted in lower blood Pb levels over time, epidemiological studies continue to provide evidence of health effects at lower and lower blood Pb levels. Low-level Pb was selected for evaluation by the National Toxicology Program (NTP) because of (1) the availability of a large number of epidemiological studies of Pb, (2) a nomination by the National Institute for Occupational Safety and Health for an assessment of Pb at lower levels of exposure, and (3) public concern for effects of Pb in children and adults. This evaluation summarizes the evidence in humans and presents conclusions on health effects in children and adults associated with low-level Pb exposure as indicated by less than 10 micrograms of Pb per deciliter of blood (< 10 microg/dL). The assessment focuses on epidemiological evidence at blood Pb levels < 10 microg/dL and < 5 microg/dL because health effects at higher blood Pb levels are well established. The NTP evaluation was conducted through the Office of Health Assessment and Translation (OHAT, formerly the Center for the Evaluation of Risks to Human Reproduction) and completed in April of 2012. The results of this evaluation are published in the NTP Monograph on Health Effects of Low-Level Lead. The document and appendices are available at http://ntp.niehs.nih.gov/go/evals. This document provides background on Pb exposure and includes a review of the primary epidemiological literature for evidence that low-level Pb is associated with neurological, immunological, cardiovascular, renal, and/or reproductive and developmental effects. The NTP Monograph presents specific conclusions for each health effect area. Overall, the NTP concludes that there is sufficient evidence that blood Pb levels < 10 microg/dL and < 5 microg/dL are associated with adverse health effects in children and adults. This conclusion was based on a review of the primary epidemiological literature, scientific input from technical advisors that reviewed pre-public release drafts of each chapter summarizing the evidence for specific health effects associated with low-level Pb, public comments received during the course of the evaluation, and comments from an expert panel of ad hoc reviewers during a public meeting to review the Draft NTP Monograph on November 17-18, 2011 (http://ntp.niehs.nih.gov/go/37090.</p>","PeriodicalId":87331,"journal":{"name":"NTP monograph","volume":" 1","pages":"xiii, xv-148"},"PeriodicalIF":0.0000,"publicationDate":"2012-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NTP monograph","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Although reductions in lead (Pb) exposure for the U.S. population have resulted in lower blood Pb levels over time, epidemiological studies continue to provide evidence of health effects at lower and lower blood Pb levels. Low-level Pb was selected for evaluation by the National Toxicology Program (NTP) because of (1) the availability of a large number of epidemiological studies of Pb, (2) a nomination by the National Institute for Occupational Safety and Health for an assessment of Pb at lower levels of exposure, and (3) public concern for effects of Pb in children and adults. This evaluation summarizes the evidence in humans and presents conclusions on health effects in children and adults associated with low-level Pb exposure as indicated by less than 10 micrograms of Pb per deciliter of blood (< 10 microg/dL). The assessment focuses on epidemiological evidence at blood Pb levels < 10 microg/dL and < 5 microg/dL because health effects at higher blood Pb levels are well established. The NTP evaluation was conducted through the Office of Health Assessment and Translation (OHAT, formerly the Center for the Evaluation of Risks to Human Reproduction) and completed in April of 2012. The results of this evaluation are published in the NTP Monograph on Health Effects of Low-Level Lead. The document and appendices are available at http://ntp.niehs.nih.gov/go/evals. This document provides background on Pb exposure and includes a review of the primary epidemiological literature for evidence that low-level Pb is associated with neurological, immunological, cardiovascular, renal, and/or reproductive and developmental effects. The NTP Monograph presents specific conclusions for each health effect area. Overall, the NTP concludes that there is sufficient evidence that blood Pb levels < 10 microg/dL and < 5 microg/dL are associated with adverse health effects in children and adults. This conclusion was based on a review of the primary epidemiological literature, scientific input from technical advisors that reviewed pre-public release drafts of each chapter summarizing the evidence for specific health effects associated with low-level Pb, public comments received during the course of the evaluation, and comments from an expert panel of ad hoc reviewers during a public meeting to review the Draft NTP Monograph on November 17-18, 2011 (http://ntp.niehs.nih.gov/go/37090.
虽然随着时间的推移,美国人口铅暴露的减少导致血铅水平降低,但流行病学研究继续提供越来越低的血铅水平对健康的影响的证据。美国国家毒理学计划(NTP)之所以选择低水平铅作为评估对象,是因为(1)有大量关于铅的流行病学研究,(2)美国国家职业安全与健康研究所(National Institute for Occupational Safety and Health)对低水平铅暴露进行评估的提名,以及(3)公众对铅对儿童和成人的影响的关注。这一评价总结了人类的证据,并就儿童和成人的低水平铅暴露对健康的影响提出了结论,即每分升血液中铅含量低于10微克(< 10微克/分升)。评估的重点是血铅水平< 10微克/分升和< 5微克/分升时的流行病学证据,因为较高血铅水平对健康的影响已得到充分证实。国家毒理规划的评估是通过健康评估和翻译办公室(OHAT,前身为人类生殖风险评估中心)进行的,并于2012年4月完成。该评估结果发表在国家毒理学规划关于低水平铅对健康影响的专论中。该文件和附录可在http://ntp.niehs.nih.gov/go/evals上获得。本文介绍了铅暴露的背景,并对主要流行病学文献进行了回顾,以寻找低水平铅与神经、免疫、心血管、肾脏和/或生殖和发育影响相关的证据。NTP专论为每个健康影响领域提出了具体的结论。总体而言,国家毒理学规划的结论是,有充分证据表明,血铅水平< 10微克/分升和< 5微克/分升与儿童和成人的不良健康影响有关。这一结论是基于对主要流行病学文献的审查、来自技术顾问的科学投入(技术顾问审查了每章公开发布前的草稿,总结了与低水平铅有关的特定健康影响的证据)、在评估过程中收到的公众意见,以及在2011年11月17日至18日审查国家毒理学控制项目专论草案的公开会议期间特设审稿人专家小组的意见(http://ntp.niehs.nih.gov/go/37090)。